First liquid biopsy to receive FDA Approval for comprehensive tumor profiling across all solid cancers, Guardant Health’s Guardant360® CDx, gains credibility among oncologists in Asia, Middle East…

The U.S. Food and Drug Administration (FDA) has approved Guardant Health’s liquid biopsy, Guardant360® CDx, for tumor mutation profiling in patients across all solid cancers. For Guardant Health Asia, Middle East and Africa (AMEA), this FDA approval represents a landmark achievement of the Guardant360 test. Currently, the liquid biopsy is commercially available in 41 countries in … Read more

AstraZeneca eyes record pharma merger with Gilead

The UK-based firm informally contacted Gilead last month to gauge its interest in a possible tie-up, the people said, asking not to be identified because the details are private. AstraZeneca didn’t specify terms for any transaction, they said. While Gilead has discussed the idea with advisers, no decisions have been made on how to proceed … Read more

Bharat Biotech set to develop and test vaccine for COVID-19

Bharat Biotech is getting into development and testing of a vaccine against COVID-19 called CoroFlu as part of an international collaboration of virologists and vaccine makers. CoroFlu is a one drop COVID-19 nasal vaccine built on a flu vaccine “backbone” that has been shown to be safe and well-tolerated in humans, in Phase I and … Read more

USFDA accepts Biocon-Mylan drug application for colon cancer

In a positive for Biocon, US drug regulator USFDA has accepted a biologics licence application by biopharmaceutical major and partner Mylan for a proposed biosimilar to treat advanced colon or rectal cancer. The application seeks approval of biosimilar bevacizumab for treatment of patients with metastatic colorectal cancer in addition to other ailments. “Once approved, our … Read more

Fractal incubated healthcare startup Qure.ai raises $16 million led by Sequoia India

Healthcare startup Qure.ai has raised $16 million in an equity funding round led by Sequoia India, with participation from MassMutual Ventures Southeast Asia, it said Thursday. MassMutual Ventures is the investment arm of US-based MassMutual Life Insurance Company. Founded in 2016 by Prashant Warier and Pooja Rao, Qure.ai provides interpretations of radiology scans within seconds, … Read more

Reliance may do a Jio like disruption in diagnostics

Reports indicate that Reliance Life Sciences (RLS) is considering a foray into India’s medical diagnostics testing industry estimated at $10bn. Current capacities are claimed to be under-utilised in the diagnostic industry.  As per Dr. A Velumani (CMD, Thyrocare), around 95 per cent of the laboratories are working under capacity, with machines lying idle. He believes … Read more